Novoprotein Scientific Inc. (SHA:688137)

Novoprotein Scientific Revenue

Novoprotein Scientific had revenue of 37.25M CNY in the quarter ending March 31, 2026, with 11.37% growth. This brings the company's revenue in the last twelve months to 150.24M, up 11.36% year-over-year. In the year 2025, Novoprotein Scientific had annual revenue of 146.44M with 14.80% growth.

• Revenue (ttm): 150.24M
• Revenue Growth: +11.36%
• P/S Ratio: 23.97
• Revenue / Employee: 265.44K
• Employees: 556
• Market Cap: 3.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	146.44M	18.88M	14.80%
Dec 31, 2024	127.56M	-25.64M	-16.73%
Dec 31, 2023	153.19M	-111.36M	-42.09%
Dec 31, 2022	264.55M	-77.34M	-22.62%
Dec 31, 2021	341.90M	162.05M	90.11%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error